Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)

5023Background: Advances in the treatment of localized CaP have led to decreased recurrences and improved OS. The Intermediate Clinical Endpoints in CaP (ICECaP) Working Group is conducting an indi...